William G. Couser. Primary Membranous Nephropathy. CJASN June 07, 2017 12: (6) 983–997; published ahead of print May 26, 2017, doi:10.2215/CJN.11761116.
Due to author error, two doses were incorrectly reported in Table 6 of the above referenced article. The doses in the text are correct. The correct doses for Table 6 are:
View this table:
Table 6.
Summary of the most common IST protocols for treating patients with primary membranous nephropathy (56–60,93)
The dose of Rituximab is 375 mg/M2.
The dose of Prednisone with Cyclosporin is 5–10 mg.
Footnotes
Published online ahead of print. Publication date available at www.cjasn.org.
- Copyright © 2017 by the American Society of Nephrology
In this issue
Jump to section
More in this TOC Section
Cited By...
- No citing articles found.